Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AliveBiome is a UK-based biotechnology and consumer healthcare company specializing in microbiome-targeted functional beverages and supplements. Founded by Thorsten Hagemann, the company utilizes a proprietary dosing cap technology to deliver high-potency, live probiotic strains—including Lactobacillus plantarum, Lactobacillus reuteri, and Lactobacillus rhamnosus—that remain stable until the point of consumption. Their flagship products are designed to support gut health, enhance the immune system, and promote overall metabolic and mental well-being. By bridging the gap between clinical microbiome research and daily nutrition, AliveBiome aims to provide food as medicine solutions for preventative healthcare. The company's products are marketed as natural, sugar-free, and vegan-friendly options for maintaining a balanced microbiome.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AliveBiome.